04.12.2012 Views

Final Programme

Final Programme

Final Programme

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Scientific Sessions<br />

14:00 - 15:30 Room N/O<br />

Molecular Imaging<br />

SS 706<br />

Oncological molecular imaging: From animal to human<br />

Moderators:<br />

K. Åhlström Riklund; Umeå/SE<br />

C. Nanni; Bologna/IT<br />

B-421 14:00<br />

Quantitative modifi cations of TNM-staging in radiation therapy patients by FDG-PET-CT<br />

N. Abolmaali, A. Koch, K. Zöphel, S. Appold, H. Hoff, M. Baumann; Dresden/DE<br />

B-422 14:09<br />

Molecular imaging of neuroendocrine tumors using Ga-68 DOTA-NOC receptor PET/CT -<br />

semiquantitative analysis after 1,257 studies<br />

R.P. Baum, V. Prasad; Bad Berka/DE<br />

B-423 14:18<br />

Can early reduction of standardized uptake value predict outcome in patients with aggressive non-<br />

Hodgkin’s lymphoma using 18 fl uorodeoxyglucose positron emission tomography?<br />

C. Lin 1 , E. Itti 1 , Y. Petegnief 2 , J. Dupuis 1 , A. Luciani 1 , M.-J. Waryn 1 , K. Belhadj 1 , T. El Gnaoui 1 , A. Rahmouni 1 ,<br />

C. Haioun 1 , M. Meignan 1 ; 1 Creteil/FR, 2 Paris/FR<br />

B-424 14:27<br />

Comparison of whole-body FDG-PET/CT and whole body MRI at 3 T for tumor staging in oncology<br />

E. Squillaci, A. Nisini, L. Antonelli, R. Danieli, O. Schillaci, G. Simonetti; Rome/IT<br />

B-425 14:36<br />

Correlation between the tumoral targeting of 111In-labeled humanized 3S193 monoclonal antibody on<br />

SPECT and tumoral uptake of 18Fluoro-fl uorodeoxyglucose on PET in small cell lung cancer<br />

E. Quaia1 , L. Krug2 , N. Pandit-Taskar2 , C. Divgi3 ; 1Trieste/IT, 2New York, NY/US, 3Philadelphia, PA/US<br />

B-426 14:45<br />

Imaging hypoxia in orthotopic rat liver tumors with the hypoxia PET tracer 124I-IAZG C.C. Riedl, P. Brader, Y. Chun, P. Zanzonico, Y. Woo, S. Carlin, C. Ling, H. Hricak, Y. Fong; New York, NY/US<br />

B-427 14:54<br />

Evaluation of uptake of folate-receptor-targeted contrast agent P866 in breast and ovarian tumors<br />

using MR imaging<br />

Z. Wang1 , O. Saborowski1 , H.-J. Raatschen1 , C. Corot2 , H. Daldrup-Link1 ; 1San Francisco, CA/US, 2Roissy/FR B-428 15:03<br />

Quantitative MRI assays of angiogenesis with microscopic correlation in a bevacizumab-treated<br />

human breast cancer model<br />

H.-J. Raatschen, B. Sennino, Y. Fu, D.M. Shames, D.M. McDonald, R.C. Brasch; San Francisco, CA/US<br />

B-429 15:12<br />

Magnetic enhancement of nanoparticle uptake in tumour cells: Combination of magnetically based<br />

labelling and magnetic heating<br />

M. Kettering1 , J. Winter1 , M. Zeisberger1 , S. Bremer-Streck1 , H. Oehring1 , C. Bergemann2 , C. Alexiou3 ,<br />

R. Hergt1 , K.-J. Halbhuber1 , W. Kaiser1 , I. Hilger1 ; 1Jena/DE, 2Berlin/DE, 3Erlangen/DE B-430 15:21<br />

In vivo magnetic resonance (MR) tracking of SPIO labelled dendritic cells (SPIO-DCs) in a model of<br />

tumor bearing mouse<br />

A. Esposito, F. De Cobelli, A. Capobianco, E. Belloni, T. Canu, A. Manfredi, A. Del Maschio; Milan/IT<br />

300 A B C D European Society of Radiology

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!